Lisinopril is not a common cause of neuropathy, but it has a documented, rare connection to nerve-related symptoms. The FDA-approved prescribing information for lisinopril lists paresthesia (tingling, numbness, or prickling sensations) as part of a broader symptom complex that can occur during treatment. There is also at least one published case report linking lisinopril to vasculitis, an inflammation of blood vessels that can damage peripheral nerves. So while neuropathy is not a typical side effect, the connection is not imaginary either.
What the Official Labeling Says
The FDA package insert for Zestril (the brand name for lisinopril) describes a symptom complex that can include paresthesia, which is the medical term for abnormal sensations like tingling, burning, or numbness in the hands and feet. This cluster of symptoms also includes joint pain, muscle aches, fever, vasculitis (blood vessel inflammation), and certain changes in blood markers. It is listed as a known but uncommon reaction, not as a primary side effect like cough or dizziness.
Paresthesia is not identical to full peripheral neuropathy, which involves actual nerve damage or dysfunction. But the sensations overlap significantly, and persistent paresthesia can be a sign that nerve function is being affected. If you are taking lisinopril and experiencing new tingling, numbness, or burning in your extremities, that symptom has a plausible link to the medication.
How Lisinopril Could Affect Nerves
Lisinopril belongs to a class of drugs called ACE inhibitors, which work by blocking an enzyme involved in blood pressure regulation. That same enzyme, called angiotensin-converting enzyme, also plays a role in pain signaling and nerve function throughout the body. A large retrospective study of roughly 800,000 people found 186 cases of complex regional pain syndrome, a severe nerve-related pain condition, specifically tied to ACE inhibitor use. People who took ACE inhibitors for longer than three months or at higher doses were at greater risk. Notably, a related class of blood pressure drugs called ARBs did not show the same association.
There is also a case report in the medical literature documenting lisinopril-induced vasculitis. When blood vessel walls become inflamed, they can restrict blood flow to peripheral nerves, starving them of oxygen and nutrients. This type of nerve damage, called vasculitic neuropathy, can produce pain, numbness, and weakness, often in an uneven pattern affecting one limb more than others.
ACE Inhibitors and Neuropathy Risk in Studies
A study published in the Journal of the American Board of Family Medicine tracked elderly patients over three years and looked at which blood pressure medications were associated with peripheral neuropathy. Among patients without diseases known to cause neuropathy, ACE inhibitors and ARBs showed no statistically significant association with nerve damage. The same was true in a subgroup of patients with diabetes.
By contrast, beta blockers were strongly associated with peripheral neuropathy in otherwise healthy patients, with roughly 3.5 times the odds compared to non-users. NSAIDs also showed a significant link, at about 2.6 times the odds. In diabetic patients specifically, calcium channel blockers were the class most clearly tied to neuropathy. ACE inhibitors did not stand out in any of these comparisons.
Interestingly, one small clinical study actually found the opposite effect. Thirteen patients given lisinopril for 12 weeks showed improvement in nerve conduction velocity, a measure of how well nerves transmit electrical signals. This suggests that for some people, particularly those with blood pressure-related nerve damage, lisinopril might help rather than harm nerve function by improving blood flow.
Distinguishing the Cause of Your Symptoms
If you take lisinopril and have neuropathy symptoms, the medication is one of many possible explanations, and statistically, it is among the less likely ones. Many people who take blood pressure medication also have diabetes, prediabetes, or metabolic syndrome, all of which are leading causes of peripheral neuropathy on their own. Vitamin B12 deficiency, alcohol use, kidney disease, and thyroid problems are other common culprits that frequently overlap with the population taking ACE inhibitors.
A few patterns can help point toward a drug-related cause. If your symptoms started within weeks to a few months of beginning lisinopril or increasing your dose, timing alone raises suspicion. Drug-induced nerve symptoms also tend to affect both sides of the body symmetrically, usually starting in the feet and hands. If your neuropathy appeared suddenly, affects only one side, or came with skin changes, swelling, or joint pain, the vasculitis-related mechanism described in lisinopril’s labeling may be worth investigating with blood work and possibly a nerve conduction study.
What Happens if You Stop Taking It
If lisinopril is contributing to your symptoms through its direct effects on pain signaling or mild blood vessel inflammation, those symptoms would generally be expected to improve after discontinuation, though the timeline varies. Paresthesia caused by a medication often begins to fade within days to weeks of stopping. Vasculitic nerve damage, if it has occurred, can take longer to resolve and in some cases may leave residual symptoms depending on severity.
Stopping lisinopril without a replacement is not safe if you are taking it for high blood pressure or heart failure. The evidence on ACE inhibitor withdrawal in heart failure patients shows meaningful clinical worsening within a few weeks for most people. If you suspect lisinopril is causing nerve symptoms, the practical path forward is a conversation about switching to a different class of blood pressure medication rather than simply stopping treatment.
Blood Pressure Drugs With Lower Neuropathy Risk
Based on the available population-level data, ACE inhibitors and ARBs are among the blood pressure drug classes least associated with neuropathy. Diuretics and alpha blockers also showed no significant link in the study of elderly patients. Beta blockers carried the highest neuropathy risk in that population, and calcium channel blockers were a concern specifically for people with diabetes.
If you and your provider decide to switch away from lisinopril to see whether your nerve symptoms improve, ARBs are often the most straightforward substitution because they lower blood pressure through a similar mechanism without directly blocking the same enzyme. This swap preserves the cardiovascular benefits while removing the specific ACE inhibitor pathway that has been linked, in rare cases, to pain syndromes and vasculitis.